Novel Agents against Miltefosine-Unresponsive Leishmania donovani.

about

Synthesis and Evaluation of Methyl 4-(7-Hydroxy-4,4,8-Trimethyl-3-Oxabicyclo[3.3.1]Nonan-2-yl)Benzoate as an Antileishmanial Agent and Its Synergistic Effect with Miltefosine.Design of commercially comparable nanotherapeutic agent against human disease-causing parasite, Leishmania.

P2860

Q50042596-5A91AFED-B4D5-4713-97BD-99CB08CCF98D Q55473147-DA00E45E-616D-4467-8AB3-701EC5B2BECA

P2860

Novel Agents against Miltefosine-Unresponsive Leishmania donovani.

Item

http://www.wikidata.org/entity/Q36290836

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Novel Agents against Miltefosine-Unresponsive Leishmania donovani.

@ast

Novel Agents against Miltefosine-Unresponsive Leishmania donovani.

@en

type

Item

label

Novel Agents against Miltefosine-Unresponsive Leishmania donovani.

@ast

Novel Agents against Miltefosine-Unresponsive Leishmania donovani.

@en

prefLabel

Novel Agents against Miltefosine-Unresponsive Leishmania donovani.

@ast

Novel Agents against Miltefosine-Unresponsive Leishmania donovani.

@en

P1476

Novel Agents against Miltefosine-Unresponsive Leishmania donovani.

@en

P2093

Anil K Saikia

http://www.w3.org/2001/XMLSchema#string

Mousumi Das

http://www.w3.org/2001/XMLSchema#string

Vikash Kumar Dubey

http://www.w3.org/2001/XMLSchema#string

P2860

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator

Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent

Drug resistance in leishmaniasis

Drug unresponsiveness & combination therapy for kala-azar.

Drug resistance in visceral leishmaniasis.

Combination therapy for visceral leishmaniasis.

Visceral leishmaniasis treatment: What do we have, what do we need and how to deliver it?

A policy for leishmaniasis with respect to the prevention and control of drug resistance.

Carbon nanotube based betulin formulation shows better efficacy against Leishmania parasite.

P304

7826-7829

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00928-15

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gundappa Saha

P577

2015-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26392497

http://www.w3.org/2001/XMLSchema#string

P932

4649250

http://www.w3.org/2001/XMLSchema#string

Novel Agents against Miltefosine-Unresponsive Leishmania donovani.

about

P2860

P2860

Novel Agents against Miltefosine-Unresponsive Leishmania donovani.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932